In addition, the increased cell survival due to overexpression of Bcl-2 has been shown to contribute to tumor development and resistance to various anti-cancer therapies (Reed et al., 1994; Inoue-Yamauchi et al., 2017; Delbridge et al., 2016). This evidence concerns the gene BCL2 and cancer.